Antengene Corporation Limited (“ Antengene “, SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing ...
The University of Cincinnati's Debanjan Bhattacharya is first author of new research published in Cancers that found the drug AM-101 improves the effectiveness and survival rate of radiation treatment ...